Source: http://www.law.cornell.edu/cfr/text/21/607.30
Timestamp: 2013-12-22 05:51:37
Document Index: 397508042

Matched Legal Cases: ['art 607', '§ 607', '§ 607', '§ 607', '§ 607', '§ 607', '§ 331', '§ 321', '§ 331', '§ 351', '§ 352', '§ 355', '§ 360', '§ 371', '§ 374', '§ 381', '§ 393', '§ 262', '§ 264', '§ 271']

21 CFR 607.30 - Updating blood product listing information. | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter F › Part 607 › Subpart B › Section 607.30 21 CFR 607.30 - Updating blood product listing information.
§ 607.30
After submission of the initial blood product listing information, every person who is required to list blood products pursuant to § 607.20 shall submit on Form FD-2830 (Blood Establishment Registration and Product Listing) during each subsequent June and December, or at the discretion of the registrant at the time the change occurs, the following information:
A list of each blood product introduced by the registrant for commercial distribution which has not been included in any list previously submitted. All of the information required by § 607.25(b) shall be provided for each such blood product.
A list of each blood product formerly listed pursuant to § 607.25(b) for which commercial distribution has been discontinued, including for each blood product so listed the identity by established name and proprietary name, and date of discontinuance. It is requested but not required that the reason for discontinuance of distribution be included with this information.
A list of each blood product for which a notice of discontinuance was submitted pursuant to paragraph (a)(2) of this section and for which commercial distribution has been resumed, including for each blood product so listed the identity by established name as defined in section 502(e) of the act and by any proprietary name, the date of resumption, and any other information required by § 607.25(b) not previously submitted.
Any material change in any information previously submitted.
When no changes have occurred since the previously submitted list, no listing information is required.
U.S. Code: Title 15 - COMMERCE AND TRADE15 U.S. Code § 331 to 374 - Omitted
U.S. Code: Title 21 - FOOD AND DRUGS21 U.S. Code § 321 - Definitions; generally21 U.S. Code § 331 - Prohibited acts21 U.S. Code § 351 - Adulterated drugs and devices21 U.S. Code § 352 - Misbranded drugs and devices21 U.S. Code § 355 - New drugs21 U.S. Code § 360 - Registration of producers of drugs or devices21 U.S. Code § 371 - Regulations and hearings21 U.S. Code § 374 - Inspection21 U.S. Code § 381 - Imports and exports21 U.S. Code § 393 - Food and Drug Administration
U.S. Code: Title 42 - THE PUBLIC HEALTH AND WELFARE42 U.S. Code § 262 - Regulation of biological products42 U.S. Code § 264 - Regulations to control communicable diseases42 U.S. Code § 271 - Penalties for violation of quarantine laws